NCT00848237 - HALO Patient Registry: Ablation of Barrett's Esophagus | Biotech Hunter

Enrollment

5,521

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Barrett Esophagus

Interventions

DEVICE

Radiofrequency Ablation (HALO Ablation Systems)

Subjects undergo ablation procedures (circumferential or focal) plus standard anti-secretory drug therapy (proton pump inhibitor, PPI). All Patients undergo endoscopy with biopsy in a Physician prescribed surveillance pattern after a negative biopsy.

Trial Locations (1)

27599-7080

Gastrointestinal Associates and sites across the US, Knoxville and Other US Cities